Latest Lars Leksell Stories
Next-generation radiosurgery solution to be unveiled April 25 BARCELONA, Spain, April 22, 2015 /PRNewswire/ -- ESTRO Booth #400 -- At the 3(rd) ESTRO Forum, April 24-28, at the Centre de Convencions
ATLANTA and STOCKHOLM, May 12 /PRNewswire/ -- A record 332 oral and poster presentations comprise the scientific program for Elekta's 15th International Leksell Gamma KnifeÂ® Society Meeting, which convenes May 16-20 at the Athenaeum InterContinental Hotel (Athens, Greece).
ATLANTA and STOCKHOLM, April 23 /PRNewswire/ -- Prof.
PALO ALTO, Calif., March 8 /PRNewswire-FirstCall/ -- Varian Medical Systems (NYSE: VAR) today announced that it has appointed John R. Adler, Jr., M.D., as Vice President and Chief of New Clinical Applications for the company. Dr.
PITTSBURGH, Dec. 22 /PRNewswire/ -- On the morning of December 17, 2009, UPMC physicians used Gamma KnifeÂ® surgery to treat the center's 10,000th patient, an 81-year-old male with a tumor deep in his brainstem, a site where traditional surgery would have been impossible.
Latest radiosurgery solutions from Elekta discussed at the 2009 AANS Meeting ATLANTA, April 30 /PRNewswire/ -- At the 2009 American Association of Neurological Surgeons (AANS) Annual Meeting, May 4-6 at the San Diego Convention Center, Elekta customers and personnel will discuss how Elekta's latest line of stereotactic treatment solutions is addressing some of the most challenging cases facing neurosurgeons and oncologists today. Local Control of Brain Mets Recent studies estimate that 25...
Regulatory News: Elekta (STO:EKTAB), a leading provider of technology for treating cancer and neurological conditions, today introduced Extend(TM)*, a new stereotactic treatment program that lets neurosurgeons and radiation oncologists apply the proven power and precision of Gamma Knife(R) surgery to an even broader class of targets in the head and neck*.
- The parings of haberdine; also, any kind of fragments.